MJFF has recently funded several studies on treatments for common, but often under-addressed non-motor symptoms in people with Parkinson's, including:
•A Phase II trial to to assess the efficacy of a current anxiety medication for addressing this symptom in Parkinson's;
•A Phase I trial on the safety and tolerability of a potential treatment for slow stomach emptying and constipation, which can cause discomfort and interfere with absorption of PD medication; and
• The development of compounds to address excessive daytime sleepiness in hopes of restoring patients' natural sleep/wake cycles